\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ demonstrated\\ decreased\\ breath\\ sounds\\ bilaterally\\.\\ \\ elevated\\ serum\\ ace\\ levels\\ were\\ also\\ found\\.\ \(0\)\
\-\ acute\\ exacerbations\\ can\\ be\\ treated\\ with\\ steroids\\.\ \(0\)\
\-\ mediastinal\\ hilar\\ lymphadenopathy\\,\\ some\\ nodules\\ are\\ calcified\\.\ \(0\)\
\-\ bilateral\\,\\ irreguar\\ septal\\ thickening\\ with\\ a\\ perilymphatic\\ distribution\\ of\\ nodules\\.\ \(0\)\
\-\ pulmonary\\ sarcoidosis\ \(3\)\
\-\ \\â\\€\\¢\\ fungal\\ infection\ \(1\)\
\-\ \\â\\€\\¢\\ tuberculosis\ \(1\)\
\-\ \\â\\€\\¢\\ primary\\ malignancy\\ \\(lymphoma\\,\\ leukemia\\,\\ bronchogenic\\ carcinoma\\)\\ or\\ metastatic\\ disease\ \(0\)\
\-\ 55\\ year\\ old\\ woman\\ with\\ chronic\\ cough\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ irreguar\\:\\ 0\\.12076052635570544\ \(0\)\
\-\ perilymphatic\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ nodules\\:\\ 0\\.09705531138089729\ \(0\)\
\-\ exacerbations\\:\\ 0\\.08921826480784181\ \(0\)\
\-\ ace\\:\\ 0\\.08194938465630523\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06439785006558443\ \(0\)\
\-\ septal\\:\\ 0\\.06378952521379214\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.061800730558388056\ \(0\)\
\-\ leukemia\\:\\ 0\\.060064405823605255\ \(0\)\
\-\ hilar\\:\\ 0\\.05881821708106107\ \(0\)\
\-\ fungal\\:\\ 0\\.056749172458967004\ \(0\)\
\-\ 55\\:\\ 0\\.056749172458967004\ \(0\)\
\-\ serum\\:\\ 0\\.056495486873114446\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.05576145610415408\ \(0\)\
\-\ steroids\\:\\ 0\\.055064765457119955\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.052872484470756674\ \(0\)\
\-\ distribution\\:\\ 0\\.05268089211493832\ \(0\)\
\-\ pe\\:\\ 0\\.052586091528026346\ \(0\)\
\-\ calcified\\:\\ 0\\.05024690338565815\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.04977719005033442\ \(0\)\
\-\ mediastinal\\:\\ 0\\.04970044682364031\ \(0\)\
\-\ levels\\:\\ 0\\.04831851223660223\ \(0\)\
\-\ sounds\\:\\ 0\\.04668968017132026\ \(0\)\
\-\ malignancy\\:\\ 0\\.04523410517536323\ \(0\)\
\-\ cough\\:\\ 0\\.044852806559014684\ \(0\)\
\-\ breath\\:\\ 0\\.043768733674648605\ \(0\)\
\-\ elevated\\:\\ 0\\.039716662484370724\ \(0\)\
\-\ thickening\\:\\ 0\\.039679788625936324\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03844801696608086\ \(0\)\
\-\ found\\:\\ 0\\.036890761841809755\ \(0\)\
\-\ some\\:\\ 0\\.03554696238173642\ \(0\)\
\-\ treated\\:\\ 0\\.03503905254909396\ \(0\)\
\-\ decreased\\:\\ 0\\.03480488222910355\ \(0\)\
\-\ primary\\:\\ 0\\.03467649675199584\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03434821893776668\ \(0\)\
\-\ pulmonary\\:\\ 0\\.03419931931808306\ \(0\)\
\-\ infection\\:\\ 0\\.03402762430236722\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0334547758135546\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03317709137008036\ \(0\)\
\-\ chronic\\:\\ 0\\.03297246072475342\ \(0\)\
\-\ metastatic\\:\\ 0\\.029467252104330002\ \(0\)\
\-\ acute\\:\\ 0\\.028902456563102672\ \(0\)\
\-\ bilateral\\:\\ 0\\.02840846204540334\ \(0\)\
\-\ woman\\:\\ 0\\.027039766403957617\ \(0\)\
\-\ were\\:\\ 0\\.026579264886163304\ \(0\)\
\-\ can\\:\\ 0\\.02655099112971328\ \(0\)\
\-\ also\\:\\ 0\\.02307698073520755\ \(0\)\
\-\ disease\\:\\ 0\\.01913339097555759\ \(0\)\
\-\ be\\:\\ 0\\.018051461963615466\ \(0\)\
\-\ are\\:\\ 0\\.01595717633602194\ \(0\)\
\-\ \\,\\:\\ 0\\.014833428247522595\ \(0\)\
\-\ or\\:\\ 0\\.013719489711831609\ \(0\)\
\-\ year\\:\\ 0\\.013097332455793352\ \(0\)\
\-\ old\\:\\ 0\\.01198540543646924\ \(0\)\
\-\ \\(\\:\\ 0\\.009895366112929595\ \(0\)\
\-\ \\)\\:\\ 0\\.009774488933058973\ \(0\)\
\-\ a\\:\\ 0\\.005432873997515086\ \(0\)\
\-\ with\\:\\ 0\\.004808390798214646\ \(0\)\
\-\ \\.\\:\\ 0\\.002917770090192844\ \(0\)\
\-\ of\\:\\ 0\\.001595942476684773\ \(0\)\
